{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:23:28Z","timestamp":1787009008927,"version":"build-2736575974"},"reference-count":6,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:00:00Z","timestamp":1684108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1193778"],"award-info":[{"award-number":["OPP1193778"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>By 1987, onchocerciasis in Niger had been successfully controlled in the six endemic river basins. In 2017, onchocerciasis elimination mapping (OEM) was carried out to determine if there was any ongoing transmission in the country as a whole.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The recommended OEM procedures were implemented.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Ten districts, that included 35 villages, required field investigation as sites of possible transmission. None of these were found capable of supporting black fly breeding, nor was there any evidence of the presence of Simulium sp. flies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The implementation of OEM indicates that there is no transmission of onchocerciasis currently taking place in these newly assessed sites in Niger.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/inthealth\/ihad032","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T05:27:36Z","timestamp":1684128456000},"page":"227-229","source":"Crossref","is-referenced-by-count":5,"title":["Successful completion of onchocerciasis elimination mapping (OEM) in Niger, West Africa"],"prefix":"10.1093","volume":"16","author":[{"given":"Salissou","family":"Adamou","sequence":"first","affiliation":[{"name":"Niger Programme Onchocercose et Filariose Lymphatique , Niamey , Niger"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Boakye","sequence":"additional","affiliation":[{"name":"Reaching the Last Mile Fund, The END Fund , New York, NY 10016 , USA"},{"name":"Noguchi Memorial Institute for Medical Research , Accra , Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laouali","family":"Bouckari","sequence":"additional","affiliation":[{"name":"Niger Programme Onchocercose et Filariose Lymphatique , Niamey , Niger"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Heggen","sequence":"additional","affiliation":[{"name":"Reaching the Last Mile Fund, The END Fund , New York, NY 10016 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Tallant","sequence":"additional","affiliation":[{"name":"Reaching the Last Mile Fund, The END Fund , New York, NY 10016 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yay\u00e9","family":"Youssouf","sequence":"additional","affiliation":[{"name":"Heller Keller International , Niamey , Niger"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4628-8188","authenticated-orcid":false,"given":"Charles D","family":"Mackenzie","sequence":"additional","affiliation":[{"name":"Reaching the Last Mile Fund, The END Fund , New York, NY 10016 , USA"},{"name":"COR-NTD, Task Force for Global Health , Atlanta, GA 30030 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,5,15]]},"reference":[{"key":"2024030418090155400_bib1","volume-title":"Twenty years of onchocerciasis control in West Africa: review of the work of the Onchocerciasis Control Programme in West Africa from 1974 to 1994","author":"World Health Organization"},{"issue":"9","key":"2024030418090155400_bib2","doi-asserted-by":"crossref","first-page":"e1825","DOI":"10.1371\/journal.pntd.0001825","article-title":"Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal","volume":"6","author":"Traore","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"2024030418090155400_bib3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pt.2011.10.003","article-title":"Elimination of onchocerciasis from Africa: possible?","volume":"28","author":"Mackenzie","year":"2012","journal-title":"Trends Parasitol"},{"key":"2024030418090155400_bib4","volume-title":"Report of the Second Meeting of the WHO Onchocerciasis Technical Advisory Subgroup","author":"World Health Organization","year":"2018"},{"issue":"Suppl 1","key":"2024030418090155400_bib5","first-page":"i17i23","article-title":"Navigating the way to onchocerciasis elimination: the feasibility and affordability of onchocerciasis elimination mapping","volume":"14","author":"Hamill","year":"2022","journal-title":"Int Health"},{"key":"2024030418090155400_bib6","volume-title":"Guidelines for stopping mass drug administration and verifying elimination of human onchocerciasis. Criteria and procedures","author":"World Health Organization","year":"2016"}],"container-title":["International Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/inthealth\/article-pdf\/16\/2\/227\/56827613\/ihad032.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/inthealth\/article-pdf\/16\/2\/227\/56827613\/ihad032.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T13:10:24Z","timestamp":1709557824000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/inthealth\/article\/16\/2\/227\/7162303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,15]]},"references-count":6,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,5,15]]},"published-print":{"date-parts":[[2024,3,4]]}},"URL":"https:\/\/doi.org\/10.1093\/inthealth\/ihad032","relation":{},"ISSN":["1876-3413","1876-3405"],"issn-type":[{"value":"1876-3413","type":"print"},{"value":"1876-3405","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,3]]},"published":{"date-parts":[[2023,5,15]]}}}